EP3419625
Aðferðir til notkunar FXR örva
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.2.2017EP published:
7.4.2021EP application number:
17709189.9
EP translation filed:
5.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
19.2.2037
Title:
METHODS FOR USING FXR AGONISTS
Timeline
Today
20.2.2017EP application
7.4.2021EP Publication
5.7.2021Translation submitted
15.8.2021Registration published
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
LAFFITTE, BryanAddress:
San Diego, California 92121, US
Name:
BADMAN, MichaelAddress:
Cambridge, Massachusetts 02139, US
Name:
CHEN, JinAddress:
East Hanover, New Jersey 07936-1080, US
Name:
LINDGREN, SamAddress:
4002 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662298121 PDate:
22.2.2016Country:
US
Number:
201662420661 PDate:
12.12.2016Country:
US
Classification
Categories:
A61K 31/46, A61P 1/00, A61P 1/16, A61K 31/4748, A61K 31/497, A61K 31/506